HealthcareServices

Population Screening Market Outlook 2026–2030: Key Business Drivers and Trends

March 2, 2026March 2, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the population screening market from 2026–2035 with trusted insights from The Business Research Company

What was the valuation of the Population Screening Market in 2026, and what figure is it projected to hit by 2030?

The population screening market size has experienced robust growth in recent years. This market is projected to expand from $31.39 billion in 2025 to $33.58 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.0%. Historically, this expansion can be linked to the broadening of public health screening initiatives, the presence of laboratory testing infrastructure, heightened disease awareness programs, the expansion of diagnostic laboratory networks, and the implementation of early detection strategies.

The population screening market is projected to experience substantial expansion in the coming years. By 2030, its value is anticipated to reach $44.61 billion, exhibiting a compound annual growth rate (CAGR) of 7.4%. This projected growth during the forecast period stems from several factors, including heightened investments in precision screening technologies, the expanded application of population-level health analytics, the broadening of national screening initiatives, the increasing incorporation of digital diagnostics, and a heightened emphasis on preventive healthcare approaches. Key trends expected during this period encompass the greater utilization of genomic screening programs, the surging adoption of AI-driven risk assessment tools, the widening scope of preventive health screening, the seamless integration of sophisticated diagnostic technologies, and improved capabilities for data interpretation.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12587&type=smp

Which Drivers Are Affecting Market Participation In The Population Screening Market?

The increasing occurrence of cancer is anticipated to drive expansion within the population screening market moving ahead. Cancer is characterized by the uncontrolled proliferation of particular cells within the human body, which can metastasize to other regions, creating serious health hazards. Early detection of cancer is facilitated by population screening, leading to better treatment results and patient outlook. As an illustration, in February 2024, the World Health Organization, an intergovernmental body based in Switzerland, reported a projection of over 35 million new cancer cases by 2050. This signifies a 77% surge when contrasted with the approximate 20 million cases in 2022. Consequently, the escalating incidence of cancer is a key factor propelling the expansion of the population screening market.

What Segment Classifications Make Up The Population Screening Market?

The population screening market covered in this report is segmented –

1) By Product: Hardware Equipment, Testing Or Lab, Analytics Or Interpretation

2) By Gender: Male, Female

3) By Age: Ages Less Than 15, 15-65, Ages 65 And Above

4) By Business: Hospitals, Research Institutes, Diagnostic Labs

Subsegments:

1) By Hardware Equipment: Diagnostic Devices, Sample Collection Devices, Imaging Equipment

2) By Testing Or Lab: Laboratory Testing Kits, Point-Of-Care Testing, Blood And Urine Testing Services

3) By Analytics Or Interpretation: Software Solutions For Data Analysis, Interpretation Services, Reporting Tools

What Trends Are Reshaping The Dynamics Of The Population Screening Market?

Major companies operating in the population screening market are pioneering advanced services, such as newborn mass screening, to improve early detection and enhance health outcomes for infants. Newborn mass screening is a public health initiative designed to test newborns shortly after birth for a variety of genetic, metabolic, hormonal, and functional disorders that may not be evident at birth but can lead to severe health complications if left untreated. For instance, in May 2024, Shimadzu Techno-Research Inc., a contract analysis firm and a subsidiary of Japan-based precision instruments manufacturer Shimadzu Corporation, launched a new contract service offering polymerase chain reaction (PCR) testing for expanded newborn mass screening. This service will identify combined immunodeficiency (SCID), B-cell deficiency (BCD), and spinal muscular atrophy (SMA), conditions that presently affect a small percentage of newborns but require immediate intervention upon diagnosis.

Which Major Industry Participants Are Leading The Population Screening Market Growth?

Major companies operating in the population screening market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Sonic Healthcare Limited, Illumina Inc., SYNLAB International GmbH, Quidel Corporation, Bio-Rad Laboratories Inc., Unilabs, Qiagen N.V., Exact Sciences Corporation, ARUP Laboratories Inc., LGC Limited, OPKO Health Inc., Natera Inc., Cerba HealthCare S.A.S, Invitae Corp, Amedes Holding GmbH, Grail, Luminex Corporation, Novogene Co. Ltd., Trinity Biotech, Gene by Gene Ltd., Innova Medical Group Inc., LabPLUS

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/population-screening-global-market-report

Which Region Is Expected To Experience The Fastest Growth In The Population Screening Market?

North America was the largest region in the population screening market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the population screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Population Screening Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12587&type=smp

Browse Through More Reports Similar to the Global Population Screening Market 2026, By The Business Research Company

Drug Screening Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-screening-global-market-report

Security Screening Market Report 2026

https://www.thebusinessresearchcompany.com/report/security-screening-global-market-report

Blood Screening Market Report 2026

https://www.thebusinessresearchcompany.com/report/blood-screening-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795